# Transcrestal Sinus Elevation with Implant Placement Using Autogenous Bone Supporting Multilayer Crosslinked Collagen Xenograft Scaffolding: A Case Series

## TL;DR

A new minimally invasive dental implant technique using a collagen scaffold and autogenous bone successfully increases bone height in patients with limited jawbone.

## Contribution

A one-stage transcrestal sinus lift protocol using a double-layer crosslinked collagen scaffold with autogenous bone is introduced for low bone height cases.

## Key findings

- Mean vertical bone gain of 3.1 mm was achieved with no postoperative complications.
- The collagen scaffold effectively sealed membrane perforations and supported bone formation.
- Implants achieved stable osseointegration with maintained augmented bone.

## Abstract

Background/Objectives: Limited residual bone height in the atrophic posterior maxilla complicates implant placement. Transcrestal sinus elevation can be used to correct bone shrinkage after sinus pneumatization or crestal bone loss. This study evaluated a minimally invasive, one-stage transcrestal sinus lift using a double-layer crosslinked collagen scaffold (MCCS) with autogenous bone from the implant osteotomy site in patients with RBH ≤ 6 mm. Methods: In this prospective series, 11 patients (48–64 years, mean RBH 4.75 mm, SD 0.95 mm) underwent one-stage transcrestal sinus floor elevation with simultaneous implants. After osteotomy, autogenous bone chips collected during drilling were compacted into the site, and two layers of MCCS were placed under the elevated Schneiderian membrane. Buccal and palatal bone heights were measured on CBCT before and after surgery to assess vertical bone gain (ΔRBH). Results: All implants achieved stable osseointegration. Mean ΔRBH was approximately 3.1 ± 0.9 mm (combined buccal–palatal). No postoperative complications occurred. Two small Schneiderian membrane perforations were sealed intraoperatively by MCCS placement, with uneventful healing. Follow-up imaging showed maintenance of the augmented bone around the implants. Conclusions: This double-layer MCCS plus autogenous bone approach is a safe, effective, and minimally invasive transcrestal sinus lift for atrophic maxillae. It yielded crestal bone gains even with minimal initial RBH, leveraging the palatal sinus wall’s osteogenic potential and the implant’s tent-pole effect. The MCCS scaffold maintained space for bone formation and enabled immediate sealing of any membrane perforations. This one-stage protocol is viable for implant placement in low-RBH sites.